• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高二级心血管疾病预防用药的依从性。

Improving adherence to medication for secondary cardiovascular disease prevention.

作者信息

Keenan Jan

机构信息

1 Oxford University Hospitals NHS Foundation Trust, UK.

2 Faculty of Health Sciences, University of Southampton, UK.

出版信息

Eur J Prev Cardiol. 2017 Jun;24(3_suppl):29-35. doi: 10.1177/2047487317708145.

DOI:10.1177/2047487317708145
PMID:28618909
Abstract

Survivors of myocardial infarction are at risk of recurrent events and have an annual death rate of 5%. Advances in treatment and, in particular, the interventional management of myocardial infarction have seen important mortality gains over recent decades, yet cardiovascular diseases remain the biggest killer in many European countries. Change in lifestyle and adherence to medication to prevent further events are key to the recurrence of future events following myocardial infarction, but adherence to medication for the secondary prevention of cardiovascular disease is a profound problem. This article outlines a growing evidence base about the complex nature of adherence as a psychological phenomenon that is influenced by the nature of the event itself, illness perception and factors related to medication beliefs that cannot be addressed simply through a combination of educational approaches. A whole-systems approach is advocated, starting with the education of health professionals to understand the psychology of adherence, and to react comfortably to patients decisions about medication, with a pivotal role for follow-up in secondary care and cardiac rehabilitation.

摘要

心肌梗死幸存者面临复发事件的风险,年死亡率为5%。在过去几十年中,治疗方面的进展,尤其是心肌梗死的介入治疗,已使死亡率显著降低,但心血管疾病在许多欧洲国家仍是最大的杀手。改变生活方式和坚持服药以预防进一步事件是心肌梗死后未来事件复发的关键,但坚持心血管疾病二级预防用药是一个严重问题。本文概述了越来越多的证据,表明依从性作为一种心理现象具有复杂性,它受到事件本身的性质、疾病认知以及与药物信念相关因素的影响,而不能仅仅通过综合教育方法来解决。提倡采用全系统方法,首先要对卫生专业人员进行教育,使其了解依从性心理,并能坦然应对患者关于用药的决定,二级护理和心脏康复中的随访起着关键作用。

相似文献

1
Improving adherence to medication for secondary cardiovascular disease prevention.提高二级心血管疾病预防用药的依从性。
Eur J Prev Cardiol. 2017 Jun;24(3_suppl):29-35. doi: 10.1177/2047487317708145.
2
Planning secondary prevention: Room for improvement.二级预防规划:仍有改进空间。
Eur J Prev Cardiol. 2017 Jun;24(3_suppl):22-28. doi: 10.1177/2047487317704954.
3
Role of the polypill for secondary prevention in ischaemic heart disease.复方制剂在缺血性心脏病二级预防中的作用。
Eur J Prev Cardiol. 2017 Jun;24(3_suppl):44-51. doi: 10.1177/2047487317707324.
4
Secondary prevention after acute myocardial infarction: drug adherence, treatment goals, and predictors of health lifestyle habits. The BLITZ-4 Registry.急性心肌梗死后的二级预防:药物依从性、治疗目标及健康生活方式习惯的预测因素。BLITZ - 4注册研究
Eur J Prev Cardiol. 2015 Dec;22(12):1548-56. doi: 10.1177/2047487314561876. Epub 2014 Dec 1.
5
Determinants of adherence to evidence-based therapy after acute myocardial infarction.急性心肌梗死后坚持循证治疗的决定因素。
Eur J Prev Cardiol. 2016 Jun;23(9):975-85. doi: 10.1177/2047487315597209. Epub 2015 Jul 21.
6
The impact of medication adherence on clinical outcomes of coronary artery disease: A meta-analysis.药物依从性对冠状动脉疾病临床结局的影响:一项荟萃分析。
Eur J Prev Cardiol. 2017 Jun;24(9):962-970. doi: 10.1177/2047487317695628. Epub 2017 Jan 1.
7
Who needs secondary prevention?谁需要二级预防?
Eur J Prev Cardiol. 2017 Jun;24(3_suppl):8-13. doi: 10.1177/2047487317706112.
8
Sex Disparities in Post-Acute Myocardial Infarction Pharmacologic Treatment Initiation and Adherence: Problem for Young Women.急性心肌梗死后药物治疗启动与依从性方面的性别差异:年轻女性面临的问题
Circ Cardiovasc Qual Outcomes. 2015 Nov;8(6):586-92. doi: 10.1161/CIRCOUTCOMES.115.001987. Epub 2015 Oct 13.
9
Medication adherence, biological and lifestyle risk factors in patients with myocardial infarction: a ten-year follow-up on socially differentiated cardiac rehabilitation.心肌梗死患者的药物依从性、生物学和生活方式风险因素:社会分化的心脏康复十年随访。
Scand J Prim Health Care. 2019 Jun;37(2):182-190. doi: 10.1080/02813432.2019.1608046. Epub 2019 May 23.
10
Adherence to therapies for secondary prevention of cardiovascular disease: a focus on aspirin.心血管疾病二级预防治疗的依从性:聚焦于阿司匹林
Cardiovasc Ther. 2016 Dec;34(6):415-422. doi: 10.1111/1755-5922.12211.

引用本文的文献

1
Racial and Ethnic Disparities in All-Cause and Cardiovascular Mortality Among Cancer Patients in the U.S.美国癌症患者全因死亡率和心血管死亡率的种族与族裔差异
JACC CardioOncol. 2023 Feb 21;5(1):55-66. doi: 10.1016/j.jaccao.2022.10.013. eCollection 2023 Feb.
2
New Strategies to Improve Patient Adherence to Medications for Noncommunicable Diseases During and After the COVID-19 Era Identified via a Literature Review.通过文献综述确定的在新冠疫情期间及之后提高患者对非传染性疾病药物依从性的新策略
J Multidiscip Healthc. 2021 Sep 7;14:2453-2465. doi: 10.2147/JMDH.S313626. eCollection 2021.
3
Doctors' views and strategies to improve patients' adherence to medication.
医生关于提高患者药物依从性的观点和策略。
Hormones (Athens). 2021 Sep;20(3):603-611. doi: 10.1007/s42000-021-00294-2. Epub 2021 Apr 29.
4
Optimising secondary prevention and cardiovascular care across Europe: A UK perspective on a common goal.优化全欧洲的二级预防和心血管护理:英国对一个共同目标的看法。
Eur J Cardiovasc Nurs. 2020 Oct;19(7):653-654. doi: 10.1177/1474515120928279. Epub 2020 Jun 9.
5
Identification of Cardiovascular Patient Groups at Risk for Poor Medication Adherence: A Cluster Analysis.识别心血管病患者药物治疗依从性差的风险群体:聚类分析。
J Cardiovasc Nurs. 2021;36(5):489-497. doi: 10.1097/JCN.0000000000000702.
6
Effect of a formalised discharge process which includes electronic delivery of prescriptions to pharmacies on the incidence of delayed prescription retrieval.规范化出院流程对延迟取药的影响,该流程包括向药店电子传送处方。
BMJ Open Qual. 2020 May;9(2). doi: 10.1136/bmjoq-2019-000849.